Aercap Holdings N.V. current report, Q3 FY2009

Business Context and Reporting Period

This Form 6-K filing by AerCap Holdings N.V. (NYSE: AER) covers the month of September 2009, specifically dated September 18, 2009. The filing reports a material corporate event: the approval of a definitive agreement to amalgamate with Genesis Lease Limited (NYSE: GLS).

Key Financial Metrics

The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The document focuses exclusively on the announcement of the proposed transaction.

Material Changes and Transaction Details

  • Transaction Type: An all share-for-share amalgamation where Genesis Lease Limited will merge with a wholly-owned subsidiary of AerCap.
  • Exchange Ratio: Genesis shareholders will receive one AerCap ordinary share for every Genesis common share owned.
  • Corporate Structure: The resulting amalgamated company will continue as a subsidiary of AerCap.
  • Approvals: The transaction has been approved by the Boards of Directors of both companies but remains subject to Genesis shareholder approval, customary closing conditions, and necessary regulatory approvals.

Guidance, Outlook, and Risks

The filing does not contain financial guidance or management commentary regarding future operational performance. Key contingencies and risks include:

  • The transaction is not yet consummated and depends on shareholder and regulatory approvals.
  • Investors are cautioned that representations and warranties in the Amalgamation Agreement are for risk allocation purposes and do not necessarily reflect the actual state of facts regarding either company.
  • Investors are not third-party beneficiaries under the agreement except for the right to receive consideration upon consummation.

Important Facts for Investor Verification

  • Verify the final exchange ratio and any potential adjustments in the upcoming Registration Statement on Form F-4.
  • Monitor the status of Genesis shareholder votes and regulatory approvals required to close the deal.
  • Review the full text of the Amalgamation Agreement (Exhibit 99.2) and the Press Release (Exhibit 99.1) for detailed terms.
  • Check for the upcoming proxy statement/prospectus to be mailed to Genesis stockholders for comprehensive transaction details.